A hemodynamically mediated mechanism of renal disease progression in severe glomerulonephritides or nephrosis

Clinical Hemorheology and Microcirculation

Volumn 29, Issue 3-4, 2003, Pages 183-187

  Futrakul, Prasit ^a   Siriviriyakul, Prasong ^a   Patumraj, Suthiluk ^a   Bunnag, Srichitra ^a   Kulaputana, Ornanong ^a   Futrakul, Narisa ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Glomerulonephritides; Hemodynamics; Nephrosis; Renal disease

Indexed keywords

CYTOKINE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; PROCOAGULANT;

ARTERIOLE; BLOOD CLOTTING; BLOOD RHEOLOGY; BLOOD VISCOSITY; CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE COURSE; EFFERENT NERVE; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; GLOMERULOSA CELL; GLOMERULUS; HEMODYNAMICS; HUMAN; HYDROSTATIC PRESSURE; HYPERCOAGULABILITY; KIDNEY DISEASE; NEPHROSIS; OXIDATIVE STRESS; PROTEINURIA; ULTRAFILTRATION; VASOCONSTRICTION;

DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; GLOMERULONEPHRITIS; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY GLOMERULUS; MODELS, BIOLOGICAL; NEPHRONS; NEPHROSIS; OXIDATIVE STRESS; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 1642439963     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. R.J. Glassock, Therapy of idiopathic nephrotic syndrome in adults, Am. J. Nephrol. 13 (1993), 422-428.
2. J.S. Cameron, D.R. Turner, C.S. Ogg et al., The long-term prognosis of patients with focal segmental glomerulosclerosis, Clin. Nephrol. 10 (1978), 213-218.
3. P. Futrakul, V. Sitprija, S. Yenrudi et al., Glomerular endothelial dysfunction determines disease progression: a hypothesis, Am. J. Nephrol. 17 (1997), 533-540.
4. M. Nagase, N. Honde and Y. Yoshitoshi, Effect of dipyridamole on glomerular negative charge in nephrotic rats induced by aminonucleoside, in: Abstract VIIIth Internat. Congr. Nephrol., 1981, p. 239.
5. T. Akiyama, R. Miyazaki, I. Otani et al., Glomerular C3b receptor, polyanion and nephritic syndrome, in: Abstract VIIIth Int. Congr. Nephrol., 1981, p. 292.
6. A.M. Malek and J. Izumo, Molecular aspects of signal transduction of shear stress in the endothelial cell, J. Hypertens. 12 (1994), 989-1000.
7. J.A. Frangos, S.G. Estein, L.V. McIntire and C.L. Ives, Flow effects on prostacyclin production by cultured human endothelial cells, Science 227 (1984), 1477-1479.
8. P. Futrakul, Coagulation in glomerulonephritis and nephrotic syndrome: its therapeutic implication, in: Asian Manual of Nephrology, T. Takeuchi, N. Suginon and K. Ota, eds, SEAMIC, Tokyo, Japan, 1981, pp. 89-96.
9. N. Futrakul, P. Futrakul and M. Poshyachinda, Transient procoagulant state of glomerular endothelium in mesangial proliferative nephrosis (MesP-NS), The FASEB J. 7 (1998), A220.
10. P. Futrakul, M. Poshyachinda and C. Mitrakul, Hypercoagulability in the nephrotic syndrome: use of anticoagulation, in: Advances in Basic Nephrology, 8th Int. Congr. Nephrol., W. Zuruhzoglu, M. Papadimitrio et al., eds, Basel, Kerger, 1981, pp. 297-301.
11. P. Futrakul, V. Poshyachinda, M. Poshyachinda et al., Nephrotic syndrome: a kinetic evaluation of hemostasis and anticoagulant therapy in children, J. Med. Assoc. Thai. 61 (1978), 309-318.
12. N. Futrakul, P. Tosukhowong, Y. Valyapongpichit et al., Oxidative stress and hemodynamic maladjustment in chronic renalDisease: a therapeutic implication, Ren. Fail. 24 (2002), 433-445.
13. N. Futrakul, P. Butthep, S. Patumraj et al., Enhanced tumor necrosis factor in the srum and renal hypoperfusion nephrosis associated with focal segmental glomerulosclerosis, Ren. Fail. 22 (2000), 213-217.
14. G. Lama, I. Luongo, G. Tirino et al., T-lymphocyte populations and cytokines in childhood nephritic syndrome, Am. J. Kidney Dis. 39 (2002), 958-965.
15. N. Futrakul, T. Panichakul, P. Chaisuriya et al., Endothelial cell cytotoxicity and renal hypoperfusion in idiopathic nephritic syndrome. Endothelial cell cytotoxicity and renal hypoperfusion in idiopathic nephritic syndrome, Nephron 86 (2000), 241-243.
16. M. Ruiz-Ortega and J. Egido, Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts, Kidney Int. 52 (1997), 497-1510.
17. N. Futrakul, S. Yenrudi, R. Sensirivatana et al., Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephritic syndrome, Ren. Fail. 22 (2000), 329-335.
18. N. Futrakul, P. Tohsukhowong, S. Patumraj et al., Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides (Submitted for publication).
19. P. Futrakul, M. Poshyachinda and C. Mitrakul, Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study, Clin. Nephrol. 10 (1978), 180-186.
20. N. Futrakul, M. Boonyen, S. Patumraj et al., Treatment of glomerular endothelial dysfunction in steroid-resistance nephrosis with ganoderma lucidum vitamins C, E and vasodilators. Clin. Hemorheol. Microcirc. 29 (2003), 205-210.
21. M. Wehrmann, A. Bohle, H. Held et al., Long-term progressis of focal sclerosing glomerulonephritis: an analysis of 250 cases with particular regard to tubulointerstitial changes, Clin. Nephrol. 33 (1990), 115-122.
22. A. Remuzzi, E. Gagliardini, C. Donadoni et al., Effects of angiotensin II antagonism on the regression of kidney disease in the rat, Kidney Int. 62 (2002), 885-894.
23. P. Futrakul, S. Yenrudi, N. Futrakul et al., Tubular function and tubulointerstitial disease, Am. J. Kidney Dis. 33 (1999), 886-891.
24. N. Futrakul, S. Yenrudi, P. Futrakul et al., Peritubular capillary flow and tubular function in idiopathic nephritic syndrome, Nephron 85 (2000), 181-182.